COVID-19: Nigeria won’t suspend hydroxychloroquine trial — NAFDAC

NAFDAC
NAFDAC

Barely 24 hours after the World Health Organisation (WHO) suspended all clinical trials for hydroxychloroquine as a potential treatment for COVID-19, the National Agency for Food and Drug Administration and Control (NAFDAC) has said the trial will continue in Nigeria.

The Director-General of the agency, Mojisola Adeyeye, made this known during an interview on Television Continental (TVC) on Tuesday.

The UN agency had on Monday said it had ‘temporarily’ suspended the clinical trials of hydroxychloroquine as a potential treatment for COVID-19 over safety concerns.

It said the decision followed a study in The Lancet that the use of the drug on COVID-19 patients could increase their likelihood of dying.

“The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board, ” WHO Director-General, Tedros Ghebreyesus said.

Chloroquine is a synthetic drug introduced in the 1940s. It is a member of an important series of chemically related agents known as quinoline derivatives. Hydroxychloroquine is a related compound that was introduced in 1955.

Clinical trials in Nigeria

Mrs Adeyeye, however, said there are proven records that hydroxychloroquine has been effective in the treatment of COVID-19 patients.

This she said is most effective in those at the mild stage of the virus.

“There is data to prove that hydroxychloroquine worked for many COVID-19 patients.

“Therefore, we would continue our own clinical trials in Nigeria.

READ ALSO: Nigeria hasn’t approved chloroquine for coronavirus treatment — Minister

“Hydroxychloroquine has been proved to work at a mild stage. So the potency depends on the severity of the disease in the patient’s body,” she said.

Treating COVID-19 with Chloroquine

There has been controversy trailing the use of chloroquine to treat COVID-19 patients.

U.S. President Donald Trump last week said he had been using hydroxychloroquine to protect himself against COVID-19.

However, Nigeria’s Presidential Task Force (PTF) on coronavirus at a daily briefing warned Nigerians against using the drug.

It said the drug has not been declared a cure for the disease and further warned of the possibility of chloroquine poisoning if one indulges in self-medication with the drug.

Dangote adbanner 728x90_2 (1)

Bauchi State governor, Bala Mohammed, who was the index case of COVID-19 in his state, had told journalists early this month that he was treated with chloroquine, zithromax, and vitamin c during his successful treatment for the disease.

The governor said COVID-19 patients in the state would, henceforth, be treated with the drugs.



Coronavirus factsheet


Advertisement

PT Mag Campaign AD

All rights reserved. This material and any other material on this platform may not be reproduced, published, broadcast, written or distributed in full or in part, without written permission from PREMIUM TIMES.


Support PREMIUM TIMES' journalism of integrity and credibility

Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.

By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.

Donate


TEXT AD: To advertise here . Call Willie +2347088095401...



BE THE FIRST TO KNOW! Subscribe to our newsletter

* indicates required

DOWNLOAD THE PREMIUM TIMES MOBILE APP

Now available on

  Premium Times Android mobile applicationPremium Times iOS mobile applicationPremium Times blackberry mobile applicationPremium Times windows mobile application